WW International Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
3analysts covering
FY EPS (est.)
-$2.84next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 5 Nov 2026 |
| Q4 2026 and Full Year Annual Report | 15 Mar 2027 |
Monitoring Framework
Key Performance Indicators
Total End of Period Subscribers Quarterly2.7M
End of Period Clinical Subscribers Quarterly197K
Clinical Subscription Revenue Quarterly39M
Adjusted Gross Margin Quarterly73.6%
Watch Items
- Behavioral Subscriber Churn RateTrigger: Sequential decline exceeding 15% in any non-seasonal quarterAction: Re-evaluate marketing spend allocation between Behavioral and Clinical segments; adjust Core+ tier pricing or features.
- Term Loan Principal PrepaymentsTrigger: Failure to execute planned cash sweep prepayments or voluntary debt reductionsAction: Review liquidity management, capital expenditure budgets, and operational cash flow generation to protect the balance sheet.
- Clinical Segment Customer Acquisition Cost (CAC)Trigger: CAC rising faster than Clinical ARPU growth over two consecutive quartersAction: Optimize digital marketing channels, leverage partnerships like LillyDirect, and refine the Med+ onboarding funnel.
Research as of 20 Jun 2026